Theranostics · 2020 · 27 citations · 40 references
MedicineOncologyPharmacologyMolecular Cell BiologyMolecular OncologyNeoplasiaMelanoma PharmacotherapyMolecular Tumor ProfilingOncogenic Signaling PathwaysReceptor Tyrosine Kinase OncogenesTargeted Cancer TherapyTargeted TherapyAurora Kinase FunctionAurora Kinase InhibitionBraf V600 MutationsBraf V600e MutationDual-target InhibitorsMolecular Drug ResistanceOncogenic Braf SignalingWestern Blot Analysis
AURKB is a potential target for melanoma treatment. HI-511, a novel dual-target inhibitor against both AURKB and BRAF V600E, could achieve durable suppression of melanoma growth, even drug-resistant melanoma growth.
40
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Zefang Tang, Chenwei Li, Chenwei Li et al. · Nucleic Acids Research · 2017 · 10.6K citations · Full text